CD19 and non-Hodgkin lymphoma: Human peripheral blood CD8+ T cells (CTL), transduced to high efficiency (>90%) with a retroviral vector encoding CD19CAR (Figure 1A), efficiently recognized and killed three representative CD19+ NHL cell lines, Ramos, Raji, and Daudi (Figure 1B).